Clinical cohort
TD
Thirty-eight TD (22 males, 16 females) and 28 ASD (20 males, 8 females) were included; 138 study visits were completed: 50 placebo (P) (26 TD, 24 ASD), 50 low-dose (L) (30 TD, 20 ASD), 38 high-dose (H) (19 TD, 19 ASD). Please see Table 